Hyperfine, Inc. (HYPR) Earnings Call Transcripts

Hyperfine, Inc.'s Latest Earnings Call - June 4, 2026

Hyperfine, Inc. reported a strong Q1 2026 with $4 million in revenue, marking an 83% year-on-year growth. The company highlighted a significant expansion in gross margins and a 50% reduction in cash burn, ending the quarter with over $40 million in cash. For FY 2026, Hyperfine provided guidance indicating a substantial revenue increase to $20-$22 million and further gross margin expansion. The company aims to reduce cash burn by 50%-55% over the next two years, projecting a cash runway through early 2028.

Reported metrics

Guidance from management

Hyperfine raised its FY 2026 revenue guidance to $20-$22 million, with expectations for gross margin expansion and a 50%-55% reduction in cash burn over the next two years.

What analysts pressed on

Analysts expressed concerns about the pace of adoption in international markets and the potential challenges in achieving broad-based adoption across diverse healthcare settings. Questions also focused on the competitive landscape and how Hyperfine's technology differentiates itself from conventional MRI solutions.

Main topics on the call

• Revenue Growth — Hyperfine reported an 83% year-on-year growth in Q1 2026, achieving $4 million in revenue. Management attributed this growth to strong market activation and adoption of their second-generation MRI technology.
• Gross Margin Expansion — The company reported a significant expansion in gross margins, with expectations to reach 50%-55% for the year. Management emphasized this as a key achievement for capital equipment in imaging.
• Regulatory Approvals — Hyperfine received CE and UKCA approvals for their second-generation system and CDSCO approval in India, marking important steps in their geographic expansion strategy.
• Clinical Study and FDA Submission — The company is conducting a clinical study for contrast brain MRI exams, which will form the basis for an FDA submission later in 2026. Management reported a healthy pace of enrollment.

Read the full Hyperfine, Inc. transcript (June 4, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 18 Hyperfine, Inc. earnings call transcripts on record, spanning March 21, 2023 to August 6, 2026. Based on this history, Hyperfine, Inc. reports quarterly. The most recent call on file is dated August 6, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

HYPR

Exchange

NasdaqGM

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

18

First call

March 21, 2023

Most recent

August 6, 2026

Reporting cadence

quarterly